Fri, Dec 26, 2014, 4:35 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

  • pfw2141 pfw2141 Jan 2, 2013 7:35 AM Flag

    Up today...........

    Aeterna Zentaris (NASDAQ:AEZS) has reached an agreement with the FDA on a Special Protocol Assessment for an upcoming Phase 3 registration trial in endometrial cancer with its doxorubicin peptide conjugate, AEZS-108. The acord states that the proposed trial protocol design, clinical endpoints and planned analyses are all acceptable to the FDA in support of a regulatory submission.

    Sentiment: Strong Buy

 
AEZS
0.5895+0.0025(+0.43%)4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.